Physiol. Genomics Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics 20: 117-130, 2004. First published October 19, 2004; doi:10.1152/physiolgenomics.00166.2004 Free Article
1094-8341/04 $5.00
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Figures
Right arrow All Versions of this Article:
20/1/117    most recent
00166.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by da Silva, R.
Right arrow Articles by Zaugg, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by da Silva, R.
Right arrow Articles by Zaugg, M.
Received 28 July 2004; accepted in final form 12 October 2004.
Physiological Genomics 20:117-130 (2004)
1094-8341/04 $5.00 © 2004 American Physiological Society

Ischemic but not pharmacological preconditioning elicits a gene expression profile similar to unprotected myocardium

Rafaela da Silva1,2,*, Eliana Lucchinetti1,2,*, Thomas Pasch2, Marcus C. Schaub1 and Michael Zaugg1,2

1 Institute of Pharmacology and Toxicology, University of Zurich
2 Institute of Anesthesiology, University Hospital Zurich, Zurich, Switzerland

Pharmacological (PPC) and ischemic preconditioning (IschPC) provide comparable protection against ischemia in the heart. However, the genomic phenotype may depend on the type of preconditioning. Isolated perfused rat hearts were used to evaluate transcriptional responses to PPC and IschPC in the presence (mediator/effector response) or absence (trigger response) of 40 min of test ischemia using oligonucleotide microarrays. IschPC was induced by 3 cycles of 5 min of ischemia, and PPC by 15 min of 2.1 vol% isoflurane. Unsupervised analysis methods were used to identify gene expression patterns. PPC and IschPC were accompanied by marked alterations in gene expression. PPC and IschPC shared only ~25% of significantly up- and downregulated genes after triggering. The two types of preconditioning induced a more uniform genomic response after ischemia/reperfusion. Numerous genes separated preconditioned from unprotected ischemic hearts. Three stable gene clusters were identified in the trigger response to preconditioning, while eight stable clusters related to cytoprotection, inflammation, remodeling, and long interspersed nucleotide elements (LINEs) were delineated after prolonged ischemia. A single stable sample cluster emerged from cluster analysis for both IschPC and unprotected myocardium, indicating a close molecular relationship between these two treatments. Principal component analysis revealed differences between PPC vs. IschPC, and trigger vs. mediator/effector responses in transcripts predominantly related to biosynthesis and apoptosis. IschPC and PPC similarly but distinctly reprogram the genetic response to ischemic injury. IschPC elicits a postischemic gene expression profile closer to unprotected myocardium than PPC, which may be therefore more advantageous as therapeutic strategy in cardioprotection.

preconditioning; gene array analysis; ischemia




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
H. Kitahata, J. Nozaki, S. Kawahito, T. Tomino, and S. Oshita
Low-Dose Sevoflurane Inhalation Enhances Late Cardioprotection from the Anti-Ulcer Drug Geranylgeranylacetone
Anesth. Analg., September 1, 2008; 107(3): 755 - 761.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J.-L. Samuel, M. C. Schaub, M. Zaugg, M. Mamas, W. B. Dunn, and B. Swynghedauw
Genomics in cardiac metabolism
Cardiovasc Res, July 15, 2008; 79(2): 218 - 227.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. Lucchinetti, J. Aguirre, J. Feng, M. Zhu, M. Suter, D. R. Spahn, L. Harter, and M. Zaugg
Molecular Evidence of Late Preconditioning After Sevoflurane Inhalation in Healthy Volunteers
Anesth. Analg., September 1, 2007; 105(3): 629 - 640.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. P. Stenzel-Poore, S. L. Stevens, J. S. King, and R. P. Simon
Preconditioning Reprograms the Response to Ischemic Injury and Primes the Emergence of Unique Endogenous Neuroprotective Phenotypes: A Speculative Synthesis
Stroke, February 1, 2007; 38(2): 680 - 685.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
N. C. Weber, J. Stursberg, N. M. Wirthle, O. Toma, W. Schlack, and B. Preckel
Xenon preconditioning differently regulates p44/42 MAPK (ERK 1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo
Br. J. Anaesth., September 1, 2006; 97(3): 298 - 306.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
E. Lucchinetti, J. Feng, R. d. Silva, G. V. Tolstonog, M. C. Schaub, G. G. Schumann, and M. Zaugg
Inhibition of LINE-1 expression in the heart decreases ischemic damage by activation of Akt/PKB signaling
Physiol Genomics, April 13, 2006; 25(2): 314 - 324.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
E. Lucchinetti, R. da Silva, T. Pasch, M. C. Schaub, and M. Zaugg
Anaesthetic preconditioning but not postconditioning prevents early activation of the deleterious cardiac remodelling programme: evidence of opposing genomic responses in cardioprotection by pre- and postconditioning
Br. J. Anaesth., August 1, 2005; 95(2): 140 - 152.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.